Towards disease modification in osteoarthritis

We share the enthusiasm of Vincent and Conaghan, and very much welcome this study, which has the potential to result, in due course, in a disease-modifying osteoarthritis drug (DMOAD).1

Source: Osteoarthritis and Cartilage - May 15, 2023 Category: Rheumatology Authors: Francesco Dell ’Accio, Cosimo De Bari Tags: Commentary Source Type: research